The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp

• Published in: The Journal of biological chemistry Vol. 268; no. 16; pp. 11479 - 11481
• Main Authors: Kuhné, M R, Pawson, T, Lienhard, G E, Feng, G S
• Format: Journal Article
• Language: English
• Published: Bethesda, MD American Society for Biochemistry and Molecular Biology 05.06.1993
• Subjects: 3T3 Cells; Adipose Tissue - cytology; Adipose Tissue - enzymology; Animals; Binding Sites; Biological and medical sciences; Cell Differentiation; Cell receptors; Cell structures and functions; Cloning, Molecular; Electrophoresis, Polyacrylamide Gel; Fundamental and applied biological sciences. Psychology; Glutathione Transferase - genetics; Glutathione Transferase - isolation & purification; Glutathione Transferase - metabolism; Hormone receptors. Growth factor receptors. Cytokine receptors. Prostaglandin receptors; Immunoblotting; Insulin Receptor Substrate Proteins; Intracellular Signaling Peptides and Proteins; Mice; Molecular and cellular biology; Phosphoproteins - isolation & purification; Phosphoproteins - metabolism; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases - genetics; Protein Tyrosine Phosphatases - isolation & purification; Protein Tyrosine Phosphatases - metabolism; Recombinant Fusion Proteins - isolation & purification; Recombinant Fusion Proteins - metabolism; SH2 Domain-Containing Protein Tyrosine Phosphatases; Sulfhydryl Compounds - metabolism; Signal transduction; Vertebrata; Mammalia; Mouse; Enzyme; Rodentia; Molecular association; Immunoblotting assay; Insulin; Hormonal receptor; Protein-tyrosine-phosphatase
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1016/S0021-9258(19)50220-4

The insulin receptor substrate 1 (IRS1) is a protein that is rapidly phosphorylated on tyrosine by the activated insulin receptor. Syp is a recently discovered, broadly expressed phosphotyrosine (Tyr(P)) phosphatase that contains two Src homology 2 (SH2) domains. We have found that insulin treatment of 3T3-L1 adipocytes leads to complex formation between IRS1 and Syp. Syp was detected in immunoadsorbates of IRS1 from extracts of insulin-treated but not basal cells by both immunoblotting and Tyr(P) phosphatase activity. The association of Syp with IRS1 apparently occurs between the SH2 domains of Syp and Tyr(P)-containing sequences of IRS1, since a fusion protein containing only the SH2 domains of Syp bound the Tyr(P) form of IRS1. Unlike the receptors for epidermal and platelet-derived growth factors, which in their activated state bind to the SH2 domains of Syp and elicit phosphorylation of Syp on tyrosine in intact cells, the Tyr(P) form of the insulin receptor did not bind to the SH2 domains of Syp, and no phosphorylation of Syp on tyrosine was detected in insulin-treated 3T3-L1 adipocytes. In combination with other findings these results indicate that IRS1 functions as a docking protein for SH2 domain-containing proteins participating in signaling from the insulin receptor.